Microbiome and cancer: mechanistic insights, diagnostic potential, and therapeutic strategies.
Modifying the gut microbiome may eventually restore immunotherapy sensitivity in some cancer patients who stop responding to treatment.
The human microbiome is now recognized as an active and dynamic participant in cancer biology rather than a passive bystander. Emerging preclinical studies and early clinical investigations suggest that microbiome modulation, including fecal microbiota transplantation (FMT), may help restore immunotherapy sensitivity in selected patients; howeve...
What the study was
- Study design
- Observational/unspecified
- Population
- cancer patients
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Frontiers in cell and developmental biology
Why it surfaced
Score 6/10 [PROMISING_PRELIMINARY]: Observational/unspecified (Journal Article) matched 'Precision oncology and genomic medicine'. Components — novelty:1/3, relevance:3/3, design:1/2, population:1/2. Confidence: medium. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.